Purchases and Sales Made in Q4 2022 in Spdr Ser Tr Spdr S&P Biotech E (XBI)
This table provides information about the institutional ownership of Spdr Ser Tr Spdr S&P Biotech E (XBI) during Q4 2022. The information is specifically focused on institutions that hold shares of SPDR SER TR SPDR S&P BIOTECH E.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 01, 2023
Q4 2022
|
Bank Of Montreal
Toronto, A6 |
SELL
|
- |
-308K- 75.78% |
$23.6M - $26.3M
|
98.3K
$9.13M
|
|
|
Feb 14, 2023
Q4 2022
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-377K- 28.32% |
$28.9M - $32.3M
|
953K
$88.5M
|
|
|
Feb 14, 2023
Q4 2022
|
Lmr Partners LLP
London, X0 |
SELL
|
- |
-395K- 52.72% |
$30.3M - $33.8M
|
354K
$32.9M
|
|
|
Feb 13, 2023
Q4 2022
|
Barclays PLC
London, X0 |
SELL
|
- |
-679K- 49.04% |
$52.1M - $58.1M
|
705K
$65.5M
|
|
|
Feb 14, 2023
Q4 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-1.31M- 15.05% |
$101M - $112M
|
7.4M
$687M
|
|
|
Feb 07, 2023
Q4 2022
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
SELL
|
- |
-1.36M- 71.11% |
$105M - $117M
|
554K
$51.5M
|
|
|
Feb 08, 2023
Q4 2022
|
Ubs Group Ag
|
SELL
|
- |
-1.37M- 51.32% |
$105M - $117M
|
1.3M
$121M
|